Atlas Trials

A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus

Clinical trial NCT07303803 · RECRUITING

Trial details

NCT number
NCT07303803
Sponsor
Shanghai Jiao Tong University School of Medicine
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
MASH - Metabolic Dysfunction-Associated SteatohepatitisT2DM (Type 2 Diabetes Mellitus)
Start date
2026-01-01
Primary completion
2030-12-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.